Telesis Bio, Inc.
TBIO · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $214,898 | $636,409 | $5,699,532 | $9,733,235 |
| - Cash | $1,570 | $30,419 | $82,806 | $13,463 |
| + Debt | $34,380 | $21,427 | $17,322 | $8,326 |
| Enterprise Value | $247,708 | $627,417 | $5,634,048 | $9,728,098 |
| Revenue | $27,509 | $27,435 | $11,043 | $6,576 |
| % Growth | 0.3% | 148.4% | 67.9% | – |
| Gross Profit | $16,950 | $15,595 | $4,299 | $3,625 |
| % Margin | 61.6% | 56.8% | 38.9% | 55.1% |
| EBITDA | -$40,493 | -$43,617 | -$36,001 | -$15,858 |
| % Margin | -147.2% | -159% | -326% | -241.1% |
| Net Income | -$47,724 | -$48,471 | -$38,958 | -$18,010 |
| % Margin | -173.5% | -176.7% | -352.8% | -273.9% |
| EPS Diluted | -1.59 | -1.65 | -1.33 | -0.62 |
| % Growth | 3.6% | -24.1% | -114.5% | – |
| Operating Cash Flow | -$34,667 | -$38,715 | -$36,698 | -$15,381 |
| Capital Expenditures | -$1,980 | -$4,468 | -$1,854 | -$204 |
| Free Cash Flow | -$36,647 | -$43,183 | -$38,552 | -$15,585 |